Academic Journal

Dynamic modulated arc therapy (DMAT): A time-aware, modulation-steered optimization framework for next-generation radiotherapy delivery.

Λεπτομέρειες βιβλιογραφικής εγγραφής
Τίτλος: Dynamic modulated arc therapy (DMAT): A time-aware, modulation-steered optimization framework for next-generation radiotherapy delivery.
Συγγραφείς: Li T; Varian Medical Systems Inc., a Siemens Healthineers company, Palo Alto, California, USA., Kuusela E; Varian Medical Systems Inc., a Siemens Healthineers company, Palo Alto, California, USA., Ruokokoski E; Varian Medical Systems Inc., a Siemens Healthineers company, Palo Alto, California, USA., Hyvönen H; Varian Medical Systems Inc., a Siemens Healthineers company, Palo Alto, California, USA., Jaboin J; Varian Medical Systems Inc., a Siemens Healthineers company, Palo Alto, California, USA., Myllykoski M; Varian Medical Systems Inc., a Siemens Healthineers company, Palo Alto, California, USA., Nurminen J; Varian Medical Systems Inc., a Siemens Healthineers company, Palo Alto, California, USA., Paananen R; Varian Medical Systems Inc., a Siemens Healthineers company, Palo Alto, California, USA., Peltola J; Varian Medical Systems Inc., a Siemens Healthineers company, Palo Alto, California, USA., Rusanen M; Varian Medical Systems Inc., a Siemens Healthineers company, Palo Alto, California, USA., Sabel M; Varian Medical Systems Inc., a Siemens Healthineers company, Palo Alto, California, USA., Moore K; Varian Medical Systems Inc., a Siemens Healthineers company, Palo Alto, California, USA., Boylan C; Varian Medical Systems Inc., a Siemens Healthineers company, Palo Alto, California, USA.
Πηγή: Journal of applied clinical medical physics [J Appl Clin Med Phys] 2026 Sep; Vol. 27 (9), pp. e70764.
Τύπος έκδοσης: Journal Article
Γλώσσα: English
Στοιχεία περιοδικού: Publisher: Wiley on behalf of American Association of Physicists in Medicine Country of Publication: United States NLM ID: 101089176 Publication Model: Print Cited Medium: Internet ISSN: 1526-9914 (Electronic) Linking ISSN: 15269914 NLM ISO Abbreviation: J Appl Clin Med Phys Subsets: MEDLINE
Imprint Name(s): Publication: 2017- : Malden, MA : Wiley on behalf of American Association of Physicists in Medicine
Original Publication: Reston, VA : American College of Medical Physics, c2000-
Ιατρικοί όροι (MeSH): Radiotherapy Planning, Computer-Assisted*/methods , Radiotherapy, Intensity-Modulated*/methods , Particle Accelerators*/instrumentation , Head and Neck Neoplasms*/radiotherapy , Neoplasms*/radiotherapy , Algorithms* , Phantoms, Imaging*, Organs at Risk/radiation effects ; Humans ; Radiotherapy Dosage
Περίληψη: Background: Conventional VMAT optimization largely treats delivery time and deliverability as emergent properties of simplified, control-point-centric models that often ignore finite acceleration and other dynamic limits. As modern linacs continue to increase maximum axis speeds and dose rates, there is a growing need for a planning paradigm that makes the plan quality-time trade-off explicit and steerable, especially when shorter treatments can provide clinical benefits beyond throughput.
Purpose: This work introduces Dynamic Modulated Arc Therapy (DMAT), a time-aware, modulation-steered framework that jointly optimizes dosimetric quality, delivery time, and modulation complexity. Here, time-aware denotes that delivery time is computed within the optimizer from an explicit model of machine dynamics, including finite acceleration and axis synchronization, rather than inferred after optimization; modulation-steered denotes that leaf-travel allowance, control-point density, total monitor units (MUs), and aperture complexity are governed together by a single user-selected modulation level, making the amount and distribution of modulation an explicit input to the optimizer. Clinical goals enter the optimizer as metric-based cost functions defined by each criterion's metric, goal value, acceptable variation, and priority, with supporting objectives generated automatically.
Methods: DMAT couples (1) direct machine emulation that accounts for axis synchronization and dynamic limits, (2) dynamic modulation control, and (3) clinical metrics as optimization cost functions. A user-selected modulation level (-3 to +3) governs leaf-travel allowance, total MU behavior, aperture-complexity penalties, and control-point (CP) density. Plans are created by defining a treatment trajectory, initializing CP geometry, leaf positions, and MU, then iteratively improving the solution with a progressive-resolution loop alternating dosimetric updates with sequencing/deliverability updates, followed by post-processing to reduce complexity with minimal dose change. CP density is adapted nonuniformly: a preliminary uniform-CP optimization is followed by redistribution according to combined delivery-complexity and geometric information. DMAT was evaluated using a hypothetical accelerated C-arm delivery system (max gantry speed 2.5 RPM, max MLC speed 6.25 cm/s, max dose rate 3000 MU/min) on representative head-and-neck, lung SBRT, and prostate SBRT cases.
Results: Across all cases, increasing modulation level produced plans with increased modulation surrogates (e.g., MU/Gy and aperture complexity) and progressively longer delivery time, while adaptive non-uniform CP allocation concentrated additional CPs in arc sectors where higher angular resolution was most beneficial. The resulting quality-time trade-off space was disease site dependent: the head-and-neck case showed substantial plan-quality gains with increased modulation and CP density, whereas prostate SBRT and lung SBRT exhibited smaller incremental quality improvements beyond baseline despite longer delivery times. When efficiency was prioritized (negative modulation levels), DMAT predictably reduced modulation and maintained a constant CP budget while shortening delivery time, producing corresponding and quantifiable reductions in plan quality.
Conclusions: DMAT establishes a time-aware, modulation-steered planning and delivery methodology in which plan quality and modulation complexity are co-optimized under explicit clinical and user control using machine-aware timing. Accurate delivery time is exposed to users during planning through advanced machine emulation. By doing so, DMAT makes quality-time trade-offs transparent, predictable, and navigable, providing a practical foundation for leveraging next-generation delivery systems' capabilities and supporting time-constrained workflows such as motion-sensitive treatments and adaptive radiotherapy.
(© 2026 The Author(s). Journal of Applied Clinical Medical Physics published by Wiley Periodicals, LLC on behalf of The American Association of Physicists in Medicine.)
References: Phys Med Biol. 2013 Nov 21;58(22):8163-77. (PMID: 24200876)
Int J Radiat Oncol Biol Phys. 2002 Jan 1;52(1):224-35. (PMID: 11777642)
Int J Radiat Oncol Biol Phys. 2013 Apr 1;85(5):1360-6. (PMID: 23154076)
Technol Cancer Res Treat. 2022 Jan-Dec;21:15330338221074501. (PMID: 35235486)
Med Phys. 1993 Nov-Dec;20(6):1709-19. (PMID: 8309444)
Med Phys. 2013 May;40(5):050701. (PMID: 23635247)
Pract Radiat Oncol. 2026 May-Jun;16(3):294-317. (PMID: 41569222)
Pract Radiat Oncol. 2011 Oct-Dec;1(4):243-50. (PMID: 24674002)
J Med Phys. 2018 Jan-Mar;43(1):52-57. (PMID: 29628634)
Med Phys. 2002 Jun;29(6):1007-18. (PMID: 12094970)
Radiother Oncol. 2013 Dec;109(3):437-41. (PMID: 24183067)
Phys Med. 2017 Aug;40:17-23. (PMID: 28712715)
J Appl Clin Med Phys. 2022 Apr;23(4):e13539. (PMID: 35084090)
J Appl Clin Med Phys. 2025 Dec;26(12):e70338. (PMID: 41316883)
Med Dosim. 2019 Winter;44(4):394-400. (PMID: 30827765)
Med Dosim. 2014 Spring;39(1):64-73. (PMID: 24360919)
Phys Med Biol. 2009 Nov 7;54(21):6439-56. (PMID: 19820268)
J Appl Clin Med Phys. 2015 Mar 08;16(2):5013. (PMID: 26103174)
Med Phys. 2009 Jun;36(6):2328-39. (PMID: 19610322)
Med Phys. 2008 Jan;35(1):310-7. (PMID: 18293586)
Phys Med Biol. 2006 Jul 7;51(13):R427-53. (PMID: 16790916)
Med Phys. 2015 Nov;42(11):6457-67. (PMID: 26520735)
Radiother Oncol. 2025 Jan;202:110596. (PMID: 39454887)
Med Phys. 2018 Jun;45(6):2399-2410. (PMID: 29659018)
Int J Radiat Oncol Biol Phys. 2021 Nov 15;111(4):936-948. (PMID: 34329738)
Front Oncol. 2023 Aug 03;13:1201500. (PMID: 37601664)
Phys Med Biol. 1995 Sep;40(9):1435-49. (PMID: 8532757)
Radiother Oncol. 2025 Jan;202:110603. (PMID: 39481608)
Cureus. 2025 Jun 18;17(6):e86280. (PMID: 40688949)
Br J Radiol. 2019 Oct;92(1102):20190270. (PMID: 31295002)
Phys Med Biol. 2011 Mar 7;56(5):R31-54. (PMID: 21297245)
Phys Imaging Radiat Oncol. 2026 Mar 03;38:100941. (PMID: 41858749)
Int J Radiat Oncol Biol Phys. 2011 Jul 15;80(4):1238-47. (PMID: 21377811)
Med Phys. 2012 Feb;39(2):686-96. (PMID: 22320778)
Med Phys. 2011 Aug;38(8):4518-30. (PMID: 21928622)
Med Phys. 2019 Oct;46(10):4304-4313. (PMID: 31310678)
J Appl Clin Med Phys. 2018 Jan;19(1):106-114. (PMID: 29152846)
Med Phys. 2009 Nov;36(11):5128-38. (PMID: 19994523)
Radiother Oncol. 2022 Mar;168:28-36. (PMID: 35017020)
Phys Med Biol. 2018 Jun 13;63(12):125013. (PMID: 29786614)
J Appl Clin Med Phys. 2024 May;25(5):e14299. (PMID: 38520072)
Int J Radiat Oncol Biol Phys. 2015 Aug 1;92(5):1148-1156. (PMID: 26050608)
Radiat Oncol. 2018 Jan 29;13(1):13. (PMID: 29378610)
Med Phys. 2015 Mar;42(3):1367-77. (PMID: 25735291)
Contributed Indexing: Keywords: VMAT; adaptive radiotherapy; delivery time; dynamic modulated arc therapy; machine emulation; modulation complexity; treatment planning
Entry Date(s): Date Created: 20260825 Date Completed: 20260825 Latest Revision: 20260827
Update Code: 20260827
PubMed Central ID: PMC13504227
DOI: 10.1002/acm2.70764
PMID: 42638435
Βάση Δεδομένων: MEDLINE
Περιγραφή
ISSN:1526-9914
DOI:10.1002/acm2.70764